Keyphrases
Clinical Practice
100%
Placebo
100%
Repetitive Transcranial Magnetic Stimulation (rTMS)
100%
Transcranial Magnetic Stimulation
100%
Parkinson's Disease
33%
Epilepsy Syndrome
33%
Ketamine Treatment
33%
Stimulation Effectiveness
16%
Potential Treatments
16%
Patient Selection
16%
Nicotine Dependence
16%
Smoking Cessation
16%
Placebo Effect
16%
Positive Outcomes
16%
Neuropsychiatric Disorders
16%
Neuropsychiatric
16%
Cigarette Consumption
16%
Patient Monitoring
16%
Improved Patient Outcomes
16%
Safety Concerns
16%
Treatment-resistant Depression
16%
Alternative Therapy
16%
Double-blind Randomized Study
16%
Cigarette Craving
16%
Comprehensive Exploration
16%
Neurological Conditions
16%
Nursing and Health Professions
Clinical Practice
100%
Placebo
100%
Repetitive Transcranial Magnetic Stimulation
100%
Transcranial Magnetic Stimulation
100%
Parkinson's Disease
33%
Ketamine
33%
Nicotine Withdrawal
16%
Tobacco Dependence
16%
Treatment Outcome
16%
Cigarette Filter
16%
Patient Selection
16%
Patient Monitoring
16%
Treatment Resistant Depression
16%
Medicine and Dentistry
Placebo
100%
Repetitive Transcranial Magnetic Stimulation
100%
Transcranial Magnetic Stimulation
100%
Parkinson's Disease
33%
Ketamine
33%
Retrospective Study
16%
Patient Selection
16%
Nicotine Withdrawal
16%
Tobacco Dependence
16%
Treatment Resistant Depression
16%
Placebo Effect
16%
Patient Monitoring
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Parkinson's Disease
100%
Ketamine
100%
Treatment Resistant Depression
50%
Retrospective Study
50%
Tobacco Dependence
50%
INIS
stimulation
100%
patients
28%
epilepsy
28%
nervous system diseases
28%
therapy
14%
applications
14%
safety
14%
monitoring
14%
exploration
14%
investigations
14%
cigarettes
14%
nicotine
14%
Neuroscience
Placebo
100%
Transcranial Magnetic Stimulation
100%
Parkinson's Disease
28%
Ketamine
28%
Treatment-Resistant Depression
14%
Tobacco Dependence
14%